Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design

NCT02149056 is registered in ClinicalTrials.gov with Affiliated Hospital of Hebei University as lead sponsor.

NCT NCT02149056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02149056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design
Lead sponsor
Affiliated Hospital of Hebei University
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
August 31, 2013
Enrollment
447 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease complicated with impaired glucose tolerance